Electrochemistry provides a point-of-care approach for the marker indicative of Pseudomonas aeruginosa infection of cystic fibrosis patients.
暂无分享,去创建一个
Jonathan P. Metters | Dimitrios K. Kampouris | Craig E Banks | C. Banks | Jonathan P Metters | Dimitrios K Kampouris
[1] Zhennan Wang,et al. Is breath acetone a biomarker of diabetes? A historical review on breath acetone measurements , 2013, Journal of breath research.
[2] J. Austin,et al. Prediction of lung cancer using volatile biomarkers in breath. , 2007, Cancer biomarkers : section A of Disease markers.
[3] P. Barnes,et al. Exhaled markers of pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[4] J. Pearson,et al. Potential sources of 2-aminoacetophenone to confound the Pseudomonas aeruginosa breath test, including analysis of a food challenge study , 2011, Journal of breath research.
[5] W. Vautz,et al. Ion mobility spectrometry for microbial volatile organic compounds: a new identification tool for human pathogenic bacteria , 2012, Applied Microbiology and Biotechnology.
[6] Jonathan P. Metters,et al. Screen printed graphite electrochemical sensors for the voltammetric determination of antimony(III) , 2013 .
[7] P. Sly,et al. Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis , 2008, European Respiratory Journal.
[8] Jonathan P. Metters,et al. Forensic electrochemistry: the electroanalytical sensing of Rohypnol® (flunitrazepam) using screen-printed graphite electrodes without recourse for electrode or sample pre-treatment. , 2013, The Analyst.
[9] P. Barnes,et al. Review of exhaled nitric oxide in chronic obstructive pulmonary disease , 2012, Journal of breath research.
[10] G. Hanna,et al. Selected ion flow tube mass spectrometry analysis of volatile metabolites in urine headspace for the profiling of gastro-esophageal cancer. , 2013, Analytical chemistry.
[11] Bogusław Buszewski,et al. Human exhaled air analytics: biomarkers of diseases. , 2007, Biomedical chromatography : BMC.
[12] C. Shannon-Weickert. BIOMARKERS , 2014, Schizophrenia Research.
[13] Anton Amann,et al. Volatile Biomarkers : Non-Invasive Diagnosis in Physiology and Medicine , 2013 .
[14] P. Španěl,et al. Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection , 2013, Journal of breath research.
[15] Amir Sharafkhaneh,et al. Exhaled nitric oxide parameters and functional capacity in chronic obstructive pulmonary disease , 2011, Journal of breath research.
[16] P. Barnes,et al. Biomarkers of some pulmonary diseases in exhaled breath , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[17] F. Mégraud. H pylori antibiotic resistance: prevalence, importance, and advances in testing , 2004, Gut.
[18] David Smith,et al. Is Hydrogen Cyanide a Marker of Burkholderia cepacia Complex? , 2013, Journal of Clinical Microbiology.
[19] G. Redding,et al. Exhaled nitric oxide predicts persistence of wheezing, exacerbations, and decline in lung function in wheezy infants and toddlers , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[20] W. Miekisch,et al. Diagnostic potential of breath analysis--focus on volatile organic compounds. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[21] Raed A. Dweik,et al. Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children , 2014, European journal of gastroenterology & hepatology.
[22] J. Jett,et al. The Analysis of Volatile Organic Compound Profiles in the Breath as a Biomarker of Lung Cancer , 2013 .
[23] Karin Greiner,et al. Elective haemodialysis increases exhaled isoprene. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] David Smith,et al. Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis. , 2005, Mass spectrometry reviews.
[25] J. Błażejowski,et al. Synthesis, structure, and properties of isomeric polyaminoacetophenones , 2004 .
[26] A. Manolis,et al. The diagnostic potential of breath analysis. , 1983, Clinical chemistry.
[27] Peter J. Sterk,et al. Volatile Metabolites of Pathogens: A Systematic Review , 2013, PLoS pathogens.
[28] David Smith,et al. Quantification of hydrogen cyanide and 2-aminoacetophenone in the headspace of Pseudomonas aeruginos , 2012 .
[29] Jonathan P. Metters,et al. Electroanalytical sensing of selenium(IV) utilising screen printed graphite macro electrodes , 2013 .
[30] Rashid O. Kadara,et al. Graphite screen printed electrodes for the electrochemical sensing of chromium(VI). , 2010, The Analyst.
[31] N. Høiby,et al. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment , 1991, The Lancet.
[32] Rashid O. Kadara,et al. Disposable highly ordered pyrolytic graphite-like electrodes: Tailoring the electrochemical reactivity of screen printed electrodes , 2010 .
[33] Rashid O. Kadara,et al. Gold Nanoparticle Modified Screen Printed Electrodes for the Trace Sensing of Arsenic(III) in the Presence of Copper(II) , 2010 .
[34] Hossam Haick,et al. Assessment, origin, and implementation of breath volatile cancer markers. , 2014, Chemical Society reviews.
[35] R. Kraemer,et al. The age at onset of chronicPseudomonas aeruginosa colonization in cystic fibrosis —prognostic significance , 2005, European Journal of Pediatrics.
[36] R. Laing,et al. 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung , 2010, BMC pulmonary medicine.